A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Conditions

Moderate to Severe Plaque Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital of Dermatology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China
Contact: Study coordinator (Lu Qianjin) · qianlu5860@gmail.com · +8613787097676

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Fountain Valley, United States · Los Angeles, United States

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Chula Vista, United States · Fountain Valley, United States

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Shanghai, China